Proinflammatory Effects of Hypoglycemia in Humans With or Without Diabetes
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Severe hypoglycemic events have been associated with increased cardiovascular mortality in patients with diabetes, which may be explained by hypoglycemia-induced inflammation. We used ex vivo stimulations of peripheral blood mononuclear cells (PBMCs) and monocytes obtained during hyperinsulinemic-euglycemic (5.0 mmol/L)-hypoglycemic (2.6 mmol/L) clamps in 11 healthy participants, 10 patients with type 1 diabetes and normal awareness of hypoglycemia (NAH), and 10 patients with type 1 diabetes and impaired awareness (IAH) to test whether the composition and inflammatory function of immune cells adapt to a more proinflammatory state after hypoglycemia. Hypoglycemia increased leukocyte numbers in healthy control participants and patients with NAH but not in patients with IAH. Leukocytosis strongly correlated with the adrenaline response to hypoglycemia. Ex vivo, PBMCs and monocytes displayed a more robust cytokine response to microbial stimulation after hypoglycemia compared with euglycemia, although it was less pronounced in patients with IAH. Of note, hypoglycemia increased the expression of markers of demargination and inflammation in PBMCs. We conclude that hypoglycemia promotes mobilization of specific leukocyte subsets from the marginal pool and induces proinflammatory functional changes in immune cells. Inflammatory responses were less pronounced in IAH, indicating that counterregulatory hormone responses are key modulators of hypoglycemia-induced proinflammatory effects. Hypoglycemia-induced proinflammatory changes may promote a sustained inflammatory state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471
Wong, K. L., Tai, J. J.-Y., Wong, W.-C., Han, H., Sem, X., Yeap, W.-H., Kourilsky, P., & Wong, S.-C. (2011) · Blood · doi:10.1182/blood-2010-12-326355 · Cited by 1,101
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825
Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471 · cited 1×
“Patients with impaired awareness of hypoglycemia (IAH) are at particularly high risk of hypoglycemia (21) because they lack hypoglycemia warning symptoms and have attenuated adrenaline responses (1,22).”
BackgroundAssociation between 7 years of intensive treatment of type 1 diabetes and long-term mortality
Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015) · JAMA · doi:10.1001/jama.2014.16107 · Cited by 437
Mechanisms of hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215228 · Cited by 433
Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes
Geddes, J., Schopman, J. E., Zammitt, N. N., & Frier, B. M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02413.x · Cited by 387
Khunti, K., Davies, M., Majeed, A., Thorsted, B. L., Wolden, M. L., & Paul, S. K. (2015) · Diabetes Care · doi:10.2337/dc14-0920 · Cited by 356
Vascular disease and diabetes: Is hypoglycaemia an aggravating factor?
Wright, R. J., & Frier, B. M. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.865 · Cited by 336 · cited 1×
“In addition, hypoglycemia has been reported to increase leukocyte counts and circulating proinflammatory cytokines in both healthy individuals (15–18) and patients with type 1 diabetes (14,19), supporting the concept that hypoglycemia-induced systemic inflammation contributes to cardiovascular complications (12,13,15).”
BackgroundHsu, P.-F., Sung, S.-H., Cheng, H.-M., Yeh, J.-S., Liu, W.-L., Chan, W.-L., Chen, C.-H., Chou, P., & Chuang, S.-Y. (2013) · Diabetes Care · doi:10.2337/dc12-0916 · Cited by 249
Gogitidze Joy, N., Hedrington, M. S., Briscoe, V. J., Tate, D. B., Ertl, A. C., & Davis, S. N. (2010) · Diabetes Care · doi:10.2337/dc09-0354 · Cited by 239
Selective Mobilization of Cytotoxic Leukocytes by Epinephrine
Dimitrov, S., Lange, T., & Born, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902189 · Cited by 236
Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects
Razavi Nematollahi, L., Kitabchi, A. E., Stentz, F. B., Wan, J. Y., Larijani, B. A., Tehrani, M. M., Gozashti, M. H., Omidfar, K., & Taheri, E. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.018 · Cited by 210 · cited 2×
“In line with previous findings (15), the results demonstrate that hypoglycemia induces leukocytosis.”
BackgroundResultEffects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation
Wright, R. J., Newby, D. E., Stirling, D., Ludlam, C. A., Macdonald, I. A., & Frier, B. M. (2010) · Diabetes Care · doi:10.2337/dc10-0013 · Cited by 208
Self‐reported non‐severe hypoglycaemic events in Europe
Östenson, C. G., Geelhoed‐Duijvestijn, P., Lahtela, J., Weitgasser, R., Markert Jensen, M., & Pedersen‐Bjergaard, U. (2014) · Diabetic Medicine · doi:10.1111/dme.12261 · Cited by 168
Severe Hypoglycemia–Induced Lethal Cardiac Arrhythmias Are Mediated by Sympathoadrenal Activation
Reno, C. M., Daphna-Iken, D., Chen, Y. S., VanderWeele, J., Jethi, K., & Fisher, S. J. (2013) · Diabetes · doi:10.2337/db13-0216 · Cited by 157
Ceriello, A., Novials, A., Ortega, E., La Sala, L., Pujadas, G., Testa, R., Bonfigli, A. R., Esposito, K., & Giugliano, D. (2012) · Diabetes · doi:10.2337/db12-0224 · Cited by 155
Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review
Hanefeld, M., Dütting, E. D., & Bramlage, P. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-135 · Cited by 104
Puente, E. C., Silverstein, J., Bree, A. J., Musikantow, D. R., Wozniak, D. F., Maloney, S., Daphna-Iken, D., & Fisher, S. J. (2010) · Diabetes · doi:10.2337/db09-1495 · Cited by 103 · cited 1×
“Frequent hypoglycemic events, typical for patients with type 1 diabetes, have been reported to protect against hypoglycemiainduced mortality (32) or neuronal damage (33) in rats.”
BackgroundJoy, N. G., Tate, D. B., Younk, L. M., & Davis, S. N. (2015) · Diabetes · doi:10.2337/db14-1729 · Cited by 99
Giménez, M., Gilabert, R., Monteagudo, J., Alonso, A., Casamitjana, R., Paré, C., & Conget, I. (2011) · Diabetes Care · doi:10.2337/dc10-1371 · Cited by 94
Willemsen, J. J., Ross, H. A., Jacobs, M. C., Lenders, J. W. M., Thien, T., Swinkels, L. M. J. W., & Benraad, T. J. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.10.1455 · Cited by 91
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes
Gruden, G., Barutta, F., Chaturvedi, N., Schalkwijk, C. G., Stehouwer, C. D. A., Witte, D. R., Fuller, J., Perin, P. C., & Bruno, G. (2012) · Diabetes Care · doi:10.2337/dc11-1531 · Cited by 84
Hypoglycemia increases serum interleukin-6 levels in healthy men and women
Dotson, S., Freeman, R., Failing, H. J., & Adler, G. K. (2008) · Diabetes Care · doi:10.2337/dc07-2243 · Cited by 70
Lu, C.-L., Shen, H.-N., Hu, S. C., Wang, J.-D., & Li, C.-Y. (2016) · Diabetes Care · doi:10.2337/dc15-2418 · Cited by 66
Janssen, M. M., Snoek, F. J., & Heine, R. J. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.529 · Cited by 57
Ceriello, A., Novials, A., Ortega, E., Pujadas, G., Sala, L. L., Testa, R., Bonfigli, A. R., & Genovese, S. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.05.003 · Cited by 52
Sejling, A., Schouwenberg, B., Færch, L., Thorsteinsson, B., de Galan, B. E., & Pedersen‐Bjergaard, U. (2015) · Diabetic Medicine · doi:10.1111/dme.12810 · Cited by 24
Abbink, E. J., Walker, A. J., van der Sluijs, H. A., Tack, C. J., & Smits, P. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.269 · Cited by 22
Self-citationHendriks, T. (1984) · Clinica Chimica Acta · doi:10.1016/0009-8981(84)90212-2 · Cited by 7
Cited by
Papachristoforou, E., Lambadiari, V., Maratou, E., & Makrilakis, K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7489795 · Cited by 479
Amiel, S. A., Aschner, P., Childs, B., Cryer, P. E., de Galan, B. E., Frier, B. M., Gonder-Frederick, L., Heller, S. R., Jones, T., Khunti, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30315-2 · Cited by 526
Abraham, M. B., Jones, T. W., Naranjo, D., Karges, B., Oduwole, A., Tauschmann, M., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12698 · Cited by 226
Sun, B., Luo, Z., & Zhou, J. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01200-7 · Cited by 168
Glycemic variability in the development of cardiovascular complications in diabetes
Nusca, A., Tuccinardi, D., Albano, M., Cavallaro, C., Ricottini, E., Manfrini, S., Pozzilli, P., & Di Sciascio, G. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3047 · Cited by 158
Metadata
- Authors
- Ratter, J. M., Rooijackers, H. M. M., Tack, C. J., Hijmans, A. G. M., Netea, M. G., de Galan, B. E., & Stienstra, R.
- Affiliations
- Radboud University Medical Center (NL)
- Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
- Corresponding author
- Ratter, Jacqueline M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2017-01-23
- Volume
- 66
- Issue
- 4
- Pages
- 1052-1061
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2580354129
- Cited by
- 94
- References
- 33
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 11 · 2023: 12 · 2022: 6 · 2021: 11 · 2020: 19 · 2019: 6 · 2018: 13 · 2017: 4
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Dutch Diabetes Research Foundation (DFN 2012.00.1542)
- European Foundation for the Study of Diabetes
- European Research Council Consolidator (310372)
- VIDI grant from the Netherlands Organisation for Scientific Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- hypoglycemia, type 1 diabetes, impaired awareness of hypoglycemia, inflammation, leukocytosis, peripheral blood mononuclear cells, monocytes, cytokine response, counterregulatory hormones, epinephrine, leukocyte mobilization, cardiovascular mortality
- MeSH terms
- Adult, Awareness, Diabetes Mellitus, Type 1, Epinephrine, Female, Glucose, Humans, Hypoglycemia, Leukocytosis, Lipopolysaccharides, Male, Monocytes, RNA, Messenger, Tumor Necrosis Factor-alpha, Glucose Clamp Technique, Gene Expression, Case-Control Studies, Cytokines, Chemokine CCL2, Lactic Acid, Interleukin-1beta, Young Adult, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.